Capstone Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$11.5M Buy
360,988
+159,814
+79% +$5.04M 0.32% 69
2017
Q1
$6.53M Buy
201,174
+791
+0.4% +$24.9K 0.18% 135
2016
Q4
$6.17M Buy
200,383
+9,866
+5% +$301K 0.18% 136
2016
Q3
$6.12M Buy
190,517
+16,996
+10% +$568K 0.18% 136
2016
Q2
$5.8M Sell
173,521
-223,979
-56% -$7.15M 0.17% 132
2016
Q1
$11.2M Sell
397,500
-6,513
-2% -$186K 0.32% 65
2015
Q4
$12.4M Buy
404,013
+244,486
+153% +$7.69M 0.36% 56
2015
Q3
$4.75M Sell
159,527
-284,998
-64% -$9.14M 0.15% 163
2015
Q2
$14.1M Buy
444,525
+268,177
+152% +$8.74M 0.41% 42
2015
Q1
$5.82M Buy
176,348
+6,642
+4% +$211K 0.16% 152
2014
Q4
$5.02M Sell
169,706
-1,743
-1% -$50K 0.15% 178
2014
Q3
$4.81M Sell
171,449
-58,164
-25% -$1.63M 0.16% 146
2014
Q2
$6.47M Sell
229,613
-168,308
-42% -$4.8M 0.21% 116
2014
Q1
$12.1M Sell
397,921
-194,600
-33% -$5.8M 0.37% 43
2013
Q4
$17.2M Sell
592,521
-392,508
-40% -$11.4M 0.5% 26
2013
Q3
$26.8M Sell
985,029
-39,237
-4% -$1.07M 0.65% 15
2013
Q2
$27.2M Buy
+1,024,266
New +$28.3M 0.72% 16

Other funds holding PFE

Capstone Asset Management's PFE Position: Q2 2017 in Review

Capstone Asset Management increased its Pfizer (PFE) stake by 79% in Q2 2017, buying an estimated $5.04M and bringing the position to 360,988 shares worth $11.5M. The position accounts for 0.32% of the portfolio, ranked #69.

Capstone Asset Management first reported a position in PFE in Q2 2013 and has held it in 17 quarters since. The position peaked at $27.2M in Q2 2013. 2,049 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

  • Capstone Asset Management held 360,988 shares of Pfizer worth $11.5M as of Q2 2017.
  • Capstone Asset Management bought 159,814 Pfizer shares in Q2 2017, an estimated $5.04M.
  • Pfizer made up 0.32% of Capstone Asset Management's portfolio in Q2 2017, its #69 holding.
  • Capstone Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 17 quarters since.
  • Capstone Asset Management's Pfizer position peaked at $27.2M in Q2 2013.
  • 2,049 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.